We are live on ! Find out more
CC

Clearline Capital Portfolio holdings

AUM $1.93B
1-Year Est. Return 38.13%
This Fund
S&P 500
This Quarter Est. Return
+0.14%
1 Year Est. Return
+38.13%
3 Year Est. Return
+17.96%
5 Year Est. Return
-8.68%
10 Year Est. Return
-18.93%
AUM
$1.73B
AUM Growth
+$1.06B
Cap. Flow
+$1.02B
Cap. Flow %
58.89%
Top 10 Hldgs %
71.38%
Holding
133
New
25
Increased
32
Reduced
24
Closed
19

Top Buys

Rank Stock Value
1
AAP icon
Advance Auto Parts
AAP
+$58.6M
2
SPB icon
Spectrum Brands
SPB
+$18.7M
3
WIX icon
WIX.com
WIX
+$18.6M
4
AMZN icon
Amazon
AMZN
+$17.9M
5
MRCY icon
Mercury Systems
MRCY
+$13.9M

Sector Composition

Rank Sector Weight
1 Technology 13.94%
2 Healthcare 10.47%
3 Consumer Discretionary 5.3%
4 Communication Services 4.52%
5 Consumer Staples 4.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LNSR icon
101
LENSAR
LNSR
$66.6M
$493K 0.03%
116,013
+63,063
+119% +$192K
LYRA
102
DELISTED
LYRA THERAPEUTICS INC
LYRA
$490K 0.03%
2,383
SPRY icon
103
ARS Pharmaceuticals
SPRY
$568M
$409K 0.02%
+61,102
New +$408K
CGNT icon
104
Cognyte Software
CGNT
$647M
$389K 0.02%
63,873
QSI icon
105
Quantum-Si Incorporated
QSI
$170M
$379K 0.02%
211,900
INUV icon
106
Inuvo
INUV
$16.5M
$342K 0.02%
+154,261
New +$445K
CTMX icon
107
CytomX Therapeutics
CTMX
$729M
$338K 0.02%
196,583
ORGNW
108
DELISTED
Origin Materials Inc Warrants
ORGNW
$292K 0.02%
395,297
NRDY.WS
109
DELISTED
Nerdy Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
NRDY.WS
$280K 0.02%
510,400
PAYO icon
110
Payoneer
PAYO
$2.41B
$257K 0.01%
53,522
EXEL icon
111
Exelixis
EXEL
$14.1B
$247K 0.01%
12,939
VINC
112
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$129K 0.01%
4,946
GDEVW icon
113
GDEV Inc Warrant
GDEVW
$60.8K
$40.6K ﹤0.01%
338,196
NUVB.WS
114
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$5.5K ﹤0.01%
33,271
API
115
Agora
API
$337M
-57,376
Closed -$208K
CCJ icon
116
Cameco
CCJ
$38.6B
-91,687
Closed -$2.4M
COUR icon
117
Coursera
COUR
$1.62B
-38,862
Closed -$448K
CPRI icon
118
Capri Holdings
CPRI
$1.81B
-4,822
Closed -$227K
EPC icon
119
Edgewell Personal Care
EPC
$1.29B
-44,131
Closed -$1.87M
GPRE icon
120
Green Plains
GPRE
$1.16B
-79,986
Closed -$2.48M
GXO icon
121
GXO Logistics
GXO
$6.17B
-204,111
Closed -$10.3M
HTZ icon
122
Hertz
HTZ
$613M
-621,379
Closed -$10.1M
LQDA icon
123
Liquidia Corp
LQDA
$7.72B
-26,042
Closed -$180K
MTCH icon
124
Match Group
MTCH
$9.07B
-12,857
Closed -$494K
PLAY icon
125
Dave & Buster's
PLAY
$356M
-7,632
Closed -$281K

Similar funds

Clearline Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Clearline Capital held 133 positions worth $1.73B, up 160% from $663M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Clearline Capital deployed $1.02B of net new capital in Q2 2023, opening 25 new positions and adding to 32 existing holdings. Its largest new stake was Advance Auto Parts: 569,183 shares worth $40M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $30.9M trimmed.

  • Clearline Capital's largest Q2 2023 buy was Advance Auto Parts: 569,183 shares worth $40M.
  • Clearline Capital added most to Spectrum Brands in Q2 2023, an estimated $18.7M increase.
  • Clearline Capital's biggest Q2 2023 reduction was Meta Platforms (Facebook), cutting an estimated $30.9M.
  • Clearline Capital fully exited Momentive Global Inc. Common Stock in Q2 2023, selling an estimated $19.1M.
  • Clearline Capital's ten largest holdings make up 71% of its $1.73B portfolio in Q2 2023.
  • Clearline Capital opened 25 new positions and closed 19 in Q2 2023.
  • Clearline Capital's portfolio value rose 160% quarter-over-quarter to $1.73B.

Based on Clearline Capital's 13F filing for Q2 2023, filed 15 Aug 2023.